ライフサイエンスコーパス: cowpox virus

1 of ATIs was confirmed in cells infected with cowpox virus.

2 ier A, a potent caspase-1 inhibitor from the cowpox virus.

3 cells challenged with the vaccinia virus or cowpox virus.

4 actor receptor family known to be encoded by cowpox virus.

5 s assays cross-reacted with newly identified cowpox viruses.

6 by either late (the AmEPV spheroidin or the cowpox virus A-type inclusion [ATI]) or early (the AmEPV

7 nt complex with A25, a truncated form of the cowpox virus A-type inclusion matrix protein.

8 d infection following footpad inoculation of cowpox virus, a natural pathogen of rodents.

9 derate activities (EC(50) 39 microM) against cowpox virus and severe acute respiratory syndrome coron

10 CrmA (a serpin from cowpox virus) and zVAD-FMK (N-benzyloxycarbonyl-Val-Ala-

11 ng extreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus and thus providing a un

12 nto the A-type inclusions (ATIs) produced by cowpox virus BR.

13 The gene is disrupted in the genome of cowpox virus Brighton Red (BR), demonstrating that altho

14 Cowpox virus Brighton red strain (CPV) contains a gene,

15 esolution crystal structure of OMCP from the cowpox virus Brighton Red strain, revealing a truncated

16 Cowpox virus (Brighton Red strain) possesses one of the

17 Exposure to 2(-5)x10(6) pfu of cowpox virus by aerosol or intranasally (inl) was lethal

18 Cowpox virus contamination was detected in 6 additional

19 The cowpox virus (CPV) CrmA and the equivalent rabbitpox vir

20 owever, CD8(+) T cells of mice infected with cowpox virus (CPV) or VV recognized APC infected with VV

21 sential for full virulence and, like crmA of cowpox virus (CPV), is reported to inhibit the interleuk

22 Further analysis revealed that, unlike cowpox virus (CPV), MPV did not interfere with MHC expre

23 egulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma viru

24 Thus, the cowpox virus (CPXV) uses genes encoding CPXV12 and CPXV2

25 nfectious Rift Valley fever virus (RVFV) and cowpox virus (CPXV) was also not affected by BST-2 expre

26 ses like variola virus, monkeypox virus, and cowpox virus (CPXV), but not vaccinia virus, encode a un

27 oximately 1.4 kb of sequence present only in cowpox virus (CPXV).

28 deletion in the CPXV012 gene in an ancestral cowpox virus created the current form of CPXV012 that is

29 In contrast, XIAP, cowpox virus CrmA and baculovirus p35 inhibited TRAIL-in

30 ence to a potent inhibitor of apoptosis from cowpox virus (crmA).

31 irus (VV) (EC(50) = 4.6 +/- 2.0 microM), and cowpox virus (CV) (EC(50) = 2.0 +/- 0.3 microM).

32 e cytomegalovirus (MCMV), vaccinia (VV), and cowpox viruses (CV).

33 In contrast, expression of CrmA, a cowpox virus-derived inhibitor of the Ced-2-like proteas

34 rom the patient's lesion tested positive for cowpox virus DNA.

35 a recombinant fusion protein comprised of a cowpox virus encoded NKG2D binding protein (OMCP) and a

36 Cowpox virus encoded protein CPXV203 blocks MHCI surface

37 DN) caspase-8, cytokine response modifier A (cowpox virus-encoded antiapoptotic protein), or DN Fas-a

38 virus encode one vTNFR, the broad host range cowpox virus encodes all vTNFRs.

39 ineering this change back into the wild-type cowpox virus genome conferred resistance to ST-246, sugg

40 Since the cowpox virus hr gene overcomes vaccinia virus host range

41 gion of the genome that is type-specific for cowpox virus identified a gene, vCD30, encoding a solubl

42 nd antiviral activity in vaccinia virus- and cowpox virus-infected human cells.

43 The efficacy of cidofovir for treatment of cowpox virus infection in BALB/c mice was investigated i

44 been reported to be orally active in lethal cowpox virus infection in mice.

45 Following cowpox virus infection in normal mice, NK cells were gre

46 irst known human case of laboratory-acquired cowpox virus infection in the United States and the ensu

47 Cowpox virus is an Orthopoxvirus that can cause infectio

48 Mutant cowpox virus lacking its MHC class I inhibitors is marke

49 he 204-bp amplicon allowed discrimination of cowpox virus (melting temperature [T(m)], 56.40 degrees

50 nal A26p, determined by complementation of a cowpox virus occlusion-defective mutant, its role in occ

51 t orthopox viruses (smallpox, monkeypox, and cowpox virus) of the synthesized nucleosides are describ

52 response modifier A (CrmA), a product of the cowpox virus, prevents programmed cell death initiated b

53 The cowpox virus protein CPXV012 deprives the endoplasmic re

54 By contrast, overexpression of the cowpox virus protein CrmA blocked apoptosis induced by e

55 The cowpox virus protein CrmA, a known inhibitor of ICE fami

56 CAP activity is inhibited by CrmA, a cowpox virus protein that prevents host cell apoptosis.

57 variola, monkeypox, camelpox, vaccinia, and cowpox virus species and strains.

58 rthopoxvirus species, similar to the current Cowpox virus species.

59 s I down-regulation on priming of functional cowpox virus-specific CD8(+) T cells.

60 combinant region consistent with a strain of cowpox virus stored in the research laboratory's freezer

61 mos cells with two different vaccinia virus (cowpox virus) strains.

62 (m)s, 61.9 to 62.2 degrees C), 40 strains of cowpox virus (T(m)s, 61.3 to 63.7 degrees C), 8 strains

63 structure to 1.85-A resolution of vCCI from cowpox virus, the prototype of this poxvirus virulence f

64 The cowpox virus V061 gene is homologous to vaccinia virus F

65 Cowpox virus variants selected in cell culture for resis